vs

Side-by-side financial comparison of QCR HOLDINGS INC (QCRH) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $107.0M, roughly 1.8× QCR HOLDINGS INC). On growth, QCR HOLDINGS INC posted the faster year-over-year revenue change (16.5% vs 13.6%). QCR HOLDINGS INC produced more free cash flow last quarter ($354.1M vs $17.6M). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs -13.2%).

QCR Holdings, Inc., through its subsidiaries, provides commercial and consumer banking, and trust and asset management services for the Quad City and Cedar Rapids communities. QCR Holdings, Inc. was founded in 1993 and is headquartered in Moline, Illinois.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

QCRH vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.8× larger
RGEN
$197.9M
$107.0M
QCRH
Growing faster (revenue YoY)
QCRH
QCRH
+2.9% gap
QCRH
16.5%
13.6%
RGEN
More free cash flow
QCRH
QCRH
$336.6M more FCF
QCRH
$354.1M
$17.6M
RGEN
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
-13.2%
QCRH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
QCRH
QCRH
RGEN
RGEN
Revenue
$107.0M
$197.9M
Net Profit
$13.3M
Gross Margin
52.5%
Operating Margin
36.1%
9.0%
Net Margin
6.7%
Revenue YoY
16.5%
13.6%
Net Profit YoY
143.9%
EPS (diluted)
$2.10
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
QCRH
QCRH
RGEN
RGEN
Q4 25
$107.0M
$197.9M
Q3 25
$101.5M
$188.8M
Q2 25
$84.2M
$182.4M
Q1 25
$76.9M
$169.2M
Q4 24
$91.8M
$174.1M
Q3 24
$152.6M
$154.9M
Q2 24
$150.6M
$154.1M
Q1 24
$141.9M
$151.3M
Net Profit
QCRH
QCRH
RGEN
RGEN
Q4 25
$13.3M
Q3 25
$36.7M
$14.9M
Q2 25
$29.0M
$14.9M
Q1 25
$25.8M
$5.8M
Q4 24
$-30.3M
Q3 24
$27.8M
$-654.0K
Q2 24
$29.1M
$3.3M
Q1 24
$26.7M
$2.1M
Gross Margin
QCRH
QCRH
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
QCRH
QCRH
RGEN
RGEN
Q4 25
36.1%
9.0%
Q3 25
40.0%
8.9%
Q2 25
36.3%
7.6%
Q1 25
34.0%
3.9%
Q4 24
36.1%
-17.7%
Q3 24
19.6%
-5.1%
Q2 24
21.0%
1.0%
Q1 24
19.7%
1.3%
Net Margin
QCRH
QCRH
RGEN
RGEN
Q4 25
6.7%
Q3 25
36.2%
7.9%
Q2 25
34.5%
8.2%
Q1 25
33.6%
3.4%
Q4 24
-17.4%
Q3 24
18.2%
-0.4%
Q2 24
19.3%
2.2%
Q1 24
18.8%
1.4%
EPS (diluted)
QCRH
QCRH
RGEN
RGEN
Q4 25
$2.10
$0.24
Q3 25
$2.16
$0.26
Q2 25
$1.71
$0.26
Q1 25
$1.52
$0.10
Q4 24
$1.77
$-0.55
Q3 24
$1.64
$-0.01
Q2 24
$1.72
$0.06
Q1 24
$1.58
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
QCRH
QCRH
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$1.1B
$2.1B
Total Assets
$9.6B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
QCRH
QCRH
RGEN
RGEN
Q4 25
$767.6M
Q3 25
$748.7M
Q2 25
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$784.0M
Q2 24
$809.1M
Q1 24
$780.6M
Total Debt
QCRH
QCRH
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
QCRH
QCRH
RGEN
RGEN
Q4 25
$1.1B
$2.1B
Q3 25
$1.1B
$2.1B
Q2 25
$1.1B
$2.1B
Q1 25
$1.0B
$2.0B
Q4 24
$997.4M
$2.0B
Q3 24
$976.6M
$2.0B
Q2 24
$936.3M
$2.0B
Q1 24
$907.3M
$2.0B
Total Assets
QCRH
QCRH
RGEN
RGEN
Q4 25
$9.6B
$2.9B
Q3 25
$9.6B
$2.9B
Q2 25
$9.2B
$2.9B
Q1 25
$9.2B
$2.9B
Q4 24
$9.0B
$2.8B
Q3 24
$9.1B
$2.8B
Q2 24
$8.9B
$2.9B
Q1 24
$8.6B
$2.8B
Debt / Equity
QCRH
QCRH
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
QCRH
QCRH
RGEN
RGEN
Operating Cash FlowLast quarter
$421.5M
$25.7M
Free Cash FlowOCF − Capex
$354.1M
$17.6M
FCF MarginFCF / Revenue
330.9%
8.9%
Capex IntensityCapex / Revenue
63.0%
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$397.4M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
QCRH
QCRH
RGEN
RGEN
Q4 25
$421.5M
$25.7M
Q3 25
$47.5M
$48.1M
Q2 25
$42.2M
$28.6M
Q1 25
$-3.6M
$15.0M
Q4 24
$444.5M
$39.2M
Q3 24
$238.1M
$49.3M
Q2 24
$26.3M
$42.2M
Q1 24
$2.7M
$44.7M
Free Cash Flow
QCRH
QCRH
RGEN
RGEN
Q4 25
$354.1M
$17.6M
Q3 25
$31.7M
$43.4M
Q2 25
$24.2M
$21.5M
Q1 25
$-12.7M
$11.4M
Q4 24
$400.0M
$33.6M
Q3 24
$229.9M
$42.3M
Q2 24
$16.2M
$37.4M
Q1 24
$-9.4M
$36.4M
FCF Margin
QCRH
QCRH
RGEN
RGEN
Q4 25
330.9%
8.9%
Q3 25
31.3%
23.0%
Q2 25
28.8%
11.8%
Q1 25
-16.5%
6.8%
Q4 24
435.6%
19.3%
Q3 24
150.7%
27.3%
Q2 24
10.7%
24.3%
Q1 24
-6.6%
24.0%
Capex Intensity
QCRH
QCRH
RGEN
RGEN
Q4 25
63.0%
4.1%
Q3 25
15.5%
2.5%
Q2 25
21.4%
3.9%
Q1 25
11.9%
2.1%
Q4 24
48.4%
3.2%
Q3 24
5.4%
4.5%
Q2 24
6.8%
3.1%
Q1 24
8.6%
5.5%
Cash Conversion
QCRH
QCRH
RGEN
RGEN
Q4 25
1.93×
Q3 25
1.29×
3.23×
Q2 25
1.46×
1.92×
Q1 25
-0.14×
2.57×
Q4 24
Q3 24
8.57×
Q2 24
0.90×
12.70×
Q1 24
0.10×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons